TechTalk Autoimmunity & Inflammation
- Thursday 7 June 2018
- De Stal
The human immune system protects us against harmful stimuli such as pathogens, toxic cellular components and cancer. However, because of various factors the immune system can become dysregulated, overactive and harmful itself. Excessive and harmful inflammation can occur during autoimmune diseases, auto-inflammatory disorders, allergies, organ transplantation, and also plays an important role in neurological disorders such as Alzheimer’s Disease and Multiple Sclerosis. Because of the complexity of these disorders most of the currently used treatments target the immune system in general.
This TechTalk gives an overview of fundamental research and drug development for several inflammatory disorders in and around the Leiden Bio Science Park.
- Innate Immunity as a therapeutic target in kidney transplantation
Prof.Dr. Cees van Kooten (Nephrology, LUMC)
- The development of drugs for the treatment of autoimmune diseases
Jan Stallen (Galapagos)
- T helper 17.1 cells as selective contributors to early multiple sclerosis
Dr. Marvin van Luijn (Immunology, Erasmus MC)
- NVLE: ‘Unmet needs for patients’
Wendy Zacouris-Verweij (NVLE)
- The B cell response in the development of rheumatoid arthritis’
Dr. Ulrich Scherer (Rheumatology, LUMC)
This event is free. Seats are unfortunately limited, so please register for this event in advance.